Literature DB >> 31980869

Falsely Accused? Insufficient Evidence to Conclude that Sitagliptin is a Cause of Chronic Cough.

Peter Dicpinigaitis1,2, Imran Satia3,4, Nadia Ferguson5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31980869     DOI: 10.1007/s00408-020-00329-2

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  15 in total

1.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors:  Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

2.  Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

Authors:  William B White; Christopher P Cannon; Simon R Heller; Steven E Nissen; Richard M Bergenstal; George L Bakris; Alfonso T Perez; Penny R Fleck; Cyrus R Mehta; Stuart Kupfer; Craig Wilson; William C Cushman; Faiez Zannad
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

Review 3.  Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.

Authors:  Peter V Dicpinigaitis
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

4.  Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report.

Authors:  Richard S Irwin; Cynthia L French; Anne B Chang; Kenneth W Altman
Journal:  Chest       Date:  2017-11-10       Impact factor: 9.410

5.  Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus.

Authors:  I Raz; M Hanefeld; L Xu; C Caria; D Williams-Herman; H Khatami
Journal:  Diabetologia       Date:  2006-09-26       Impact factor: 10.122

Review 6.  Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis.

Authors:  K Gooßen; S Gräber
Journal:  Diabetes Obes Metab       Date:  2012-05-17       Impact factor: 6.577

7.  Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase.

Authors:  Marjolein J Willemen; Aukje K Mantel-Teeuwisse; Sabine M Straus; Ron H Meyboom; Toine C Egberts; Hubert G Leufkens
Journal:  Diabetes Care       Date:  2011-02       Impact factor: 19.112

8.  Rhinorrhea, cough and fatigue in patients taking sitagliptin.

Authors:  James N Baraniuk; Mary J Jamieson
Journal:  Allergy Asthma Clin Immunol       Date:  2010-05-12       Impact factor: 3.406

9.  Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Jennifer B Green; M Angelyn Bethel; Paul W Armstrong; John B Buse; Samuel S Engel; Jyotsna Garg; Robert Josse; Keith D Kaufman; Joerg Koglin; Scott Korn; John M Lachin; Darren K McGuire; Michael J Pencina; Eberhard Standl; Peter P Stein; Shailaja Suryawanshi; Frans Van de Werf; Eric D Peterson; Rury R Holman
Journal:  N Engl J Med       Date:  2015-06-08       Impact factor: 91.245

Review 10.  Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

Authors:  Renee E Amori; Joseph Lau; Anastassios G Pittas
Journal:  JAMA       Date:  2007-07-11       Impact factor: 56.272

View more
  2 in total

1.  LUNG Year in Review: 2020.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2021-01-26       Impact factor: 2.584

2.  Influence of age, sex and respiratory viruses on the rates of emergency department visits and hospitalisations with respiratory tract infections, asthma and COPD.

Authors:  Imran Satia; Adil Adatia; Ruth P Cusack; Justina M Greene; Paul M O'Byrne; Kieran J Killian; Neil Johnston
Journal:  ERJ Open Res       Date:  2021-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.